Filing Details
- Accession Number:
- 0001042167-24-000039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-17 19:41:40
- Reporting Period:
- 2024-05-15
- Accepted Time:
- 2024-05-17 19:41:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
863894 | Veru Inc. | VERU | Pharmaceutical Preparations (2834) | 391144397 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1276244 | Shuster Mitchell Steiner | 2916 North Miami Avenue Suite 1000 Miami FL 33127 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-05-15 | 84,021 | $1.50 | 7,100,746 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-05-16 | 59,788 | $1.41 | 7,040,958 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-05-17 | 28,066 | $1.32 | 7,012,892 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 144,000 | Indirect | Footnote |
Footnotes
- Dr. Steiner sold the shares referenced above to help address certain personal matters. The sold shares represent only 1.7% of Dr. Steiner's total beneficial ownership in the Company. After these sales, Dr. Steiner will beneficially own 9,686,180 shares, and will continue to be the Company's second largest shareholder.
- The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.4800 to $1.5200. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
- The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.3800 to $1.4650. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
- The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.3000 to $1.3450. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
- Shares are held by four individual trusts with each trust for the benefit of an adult child of the reporting person. The reporting person is the trustee of each of the trusts. The reporting person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.